Follow-The-Filings

Security · featured owners

GMED Globus Med Inc.

Health Care CL A Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $475K
  • 2 exits

GMED (Globus Med Inc.) is held in 1 featured 13F book as of 2026 Q2. Ruane, Cunniff & Goldfarb is the largest tracked holder by portfolio weight (0.01%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (Ruane, Cunniff & Goldfarb) · not free-float ownership

  1. Ruane, Cunniff & Goldfarb 0.01%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Ruane, Cunniff & Goldfarb 2026 Q2 0.01% Hold 6,008 $475K History
Lee Ainslie - Maverick Capital exited 2026 Q2 Last 2026 Q1 0.02% Exit −0.02% 15,660 $1M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 4,000 $345K History

1 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Jul 27, 2026 Filing Doc
4 Period Jun 5, 2026 Filing Doc
4 Period Jun 4, 2026 Filing Doc
4 Period Feb 25, 2026 Filing Doc
4 Period Feb 12, 2026 Filing Doc
4 Period Jan 21, 2026 · 13 forms Filing Doc
4/A Period Dec 1, 2025 Filing Doc
4 Period Jan 8, 2026 · 2 forms Filing Doc
4 Period Jan 2, 2026 Filing Doc
4 Period Dec 12, 2025 Filing Doc

Updated 13 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.57B $2.52B $2.94B
Gross profit * $1.02B $1.48B $1.98B
Gross margin * 65.1% 58.9% 67.4%
Net income $122.87M $102.98M $537.87M
Net margin * 7.8% 4.1% 18.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.92B $2.18B $2.13B
Total non-current assets * $3.17B $3.07B $3.18B
Total assets $5.09B $5.25B $5.3B
Total current liabilities $392.35M $855.91M $498.5M
Total non-current liabilities * $695.78M $218.5M $231.01M
Total equity $4B $4.18B $4.57B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $243.5M $520.64M $753.45M
Cash from investing $302.97M -$176.05M -$355.01M
Cash from financing -$231.82M -$27.7M -$679.16M
Net change in cash $316.83M $317.15M -$258.28M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders